Skip to main content
. 2018 Sep 19;7(10):5299–5314. doi: 10.1002/cam4.1774

Table 3.

Most likely clusters of childhood cancer detected by SaTScan and FleXScan, on the living zone and département scales (2000‐2014)

Diagnostic groups and subgroups N 1898 LZ 94 Départements
SaTScan FleXScan SaTScan FleXScan
Units O E P Units O E P Units O E P Units O E P
Malignant hematopoietic tumors
Leukemias, myeloproliferative and myelodysplastic diseases 7447 94 325 262.1 0.93 11 55 28.2 0.49 11 562 490.6 0.55 12 893 774.9 0.12
Acute lymphoid leukemias 5854 51 166 118.7 0.69 13 67 32.5 0.10 17 698 611.0 0.25 12 731 621.2 0.06
Acute myeloid leukemias 1078 7 8 1.2 0.64 6 11 2.4 0.71 7 233 191.9 0.59 11 208 161.8 0.40
Lymphomas 2832 48 132 85.3 0.09 6 17 4.5 0.45 17 431 358.7 0.09 9 285 216.1 0.04
Hodgkin lymphomas 1262 94 84 51.2 0.43 7 13 3.1 0.63 5 69 41.5 0.10 6 79 48.7 0.21
Burkitt l ymphomas 699 4 9 1.0 0.07 5 10 1.2 0.07 19 129 96.8 0.42 12 131 92.0 0.18
Other lymphomas 871 5 12 1.3 <0.01 5 12 1.3 0.01 3 37 18.6 0.15 11 85 50.0 0.04
CNS tumors 6359 97 325 240.7 0.02 23 213 138.7 0.02 11 497 392.9 <0.01 9 478 367.3 <0.01
Ependymomas and choroid plexus tumors 625 5 10 1.3 0.08 2 5 0.4 0.42 6 43 28.2 0.94 13 73 50.3 0.86
Embryonal CNS tumors 1228 12 12 2.7 0.53 3 7 1.1 0.90 17 156 118.6 0.35 12 122 86.3 0.43
Gliomas 3898 57 204 131.9 <0.01 22 136 77.0 0.01 11 337 241.3 <0.01 10 328 225.2 <0.01
Pilocytic astrocytomas 1409 8 11 2.7 0.91 9 28 12.2 0.85 9 243 200.7 0.64 12 202 171.5 0.66
Other gliomas 2489 97 159 95.1 <0.01 33 75 28.5 <0.01 11 230 154.4 <0.01 8 204 129.4 <0.01
Embryonal tumors
Neuroblastomas 2101 65 127 83.5 0.22 13 38 16.1 0.31 6 184 137.1 0.10 13 380 309.2 0.12
Retinoblastomas 742 45 33 16.8 0.99 8 17 5.3 0.53 2 49 28.7 0.31 7 143 99.4 0.08
Nephroblastomas 1415 18 14 3.0 0.18 14 24 5.6 0.03 11 270 221.9 0.39 12 301 240.8 0.20
Hepatoblastomas 218 2 3 0.1 0.63 1 2 0.0 0.60 2 7 1.6 0.56 11 36 21.1 0.84
Malignant bone and soft tissue tumors
Malignant bone tumors 1225 41 31 13.4 0.60 10 23 8.6 0.68 6 62 37.2 0.16 8 106 70.1 0.18
Osteosarcomas 576 4 6 0.5 0.37 4 6 0.5 0.31 6 125 91.7 0.23 14 181 138.9 0.26
Ewing tumors 556 32 14 3.2 0.25 4 6 0.5 0.23 3 16 5.5 0.22 7 34 16.8 0.40
Soft tissue and other extraosseous sarcomas 1654 4 6 0.6 0.60 8 14 4.3 0.95 7 187 150.6 0.74 12 395 330.4 0.30
Rhabdomyosarcomas 899 2 6 0.7 0.87 2 6 0.7 0.80 9 98 72.7 0.77 12 249 203.0 0.51
Other soft tissue sarcomas 755 60 28 11.9 0.69 6 9 2.0 0.87 12 122 90.4 0.40 10 113 81.0 0.55
Germ‐cell tumors, trophoblastic tumors, and neoplasms of gonads 836 33 24 8.4 0.25 2 7 1.4 0.99 5 106 78.8 0.68 10 166 127.6 0.54
Intracranial and intraspinal GCTs 229 7 4 0.33 0.95 2 2 0.1 0.98 4 12 4.72 0.83 10 23 10.76 0.73
Malignant extracranial and extragonadal GCT 263 5 5 0.35 0.42 1 3 0.1 0.33 5 11 3.69 0.62 13 33 16.15 0.35
Malignant gonadal GCT 318 44 17 4.8 0.28 2 4 0.3 0.72 7 73 53.8 0.89 9 84 60.2 0.81
All cancers 25 877 82 1210 1061.4 0.26 26 720 587.8 0.12 10 1789 1605.2 0.01 10 2519 2278.7 0.01

CNS, Central nervous system; GCT, Germ cell tumors.

N: total number of observed cases (islands excluded). units: number of geographic units (LZ or département) included in the most likely cluster zone. O and E: observed and expected numbers of cases in the most likely cluster zone. P: statistical significance threshold after 999 and 9999 Monte Carlo simulations on the LZ and département scales, respectively.